Abiopharma

🔍 BELANOFF JOSEPH K (Executive)

Company: CORCEPT THERAPEUTICS INC (CORT)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Sold 26,198 shares of Common Stock at $50.0735 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 2,918,326.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
• F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $50.00 to $50.32 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F3: Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
• REMARKS: The power of attorney under which this form was signed is on file with the Commission.